NETRAMARK

What this means for you

Not registered yet, but its 27 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97813502

Mark type

Stylized text

Filed

27 Feb 2023

Attorney of record

James M. Urzedowski

Goods and services

• Class 009 — Scientific and electric apparatus: Downloadable and recorded computer software for analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; downloadable and recorded computer software for analyzing molecular and clinical data for scientific and medical research; downloadable and recorded computer software for data automation and data collection to evaluate, analyze and collect clinical research data in the field of clinical trials; downloadable and recorded computer system software for the integration of artificial intelligence and machine learning in the field of big data for business data analytics and clinical trial analytics
• Class 035 — Advertising and business services: Business consulting services concerning the regulatory approval process for pharmaceuticals; providing independent review of clinical trials in the pharmaceutical, biotechnology and life sciences fields for business purposes; providing consulting services in the field of regulatory submission management to pharmaceutical companies to assist them with applications for pharmaceutical regulatory approval
• Class 042 — Scientific and technological services: Scientific analysis of clinical trials in the pharmaceutical, biotechnology and life sciences fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting chemical molecular analysis, designing and testing new products to optimize efficacy, and conducting clinical trials, all for pharmaceutical industries; Software as a service (SaaS) services featuring software for analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; software as a service (SaaS) services featuring software for analyzing molecular and clinical data for scientific and medical research; data automation and data collection using software to evaluate, analyze and collect clinical research data in the field of pharmaceutical regulatory approval; providing online non-downloadable computer system software for the integration of artificial intelligence and machine learning in the field of big data for business data analytics and clinical trial analytics

Owner

• NetraMark Corp., Toronto, ON, CA

Prosecution history

• 27 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 27 Mar 2026 — NON-FINAL ACTION E-MAILED
• 27 Mar 2026 — NON-FINAL ACTION WRITTEN
• 27 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 27 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 18 Feb 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
• 01 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 01 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 10 Sept 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
• 10 Sept 2025 — INQUIRY TO SUSPENSION E-MAILED
• 10 Sept 2025 — SUSPENSION INQUIRY WRITTEN
• 23 Jul 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 22 Jan 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 22 Jan 2025 — LETTER OF SUSPENSION E-MAILED
• 22 Jan 2025 — SUSPENSION LETTER WRITTEN